Analysis of chromameter results obtained from corticosteroid-induced skin blanching assay: Comparison of visual and chromameter data

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 47, Issue 3, 1999, Pages 261-267

  Schwarb, Fabian P ^a,c   W Smith, Eric ^b,c   Haigh, John M ^c   Surber, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b OHIO NORTHERN UNIVERSITY   (United States)

^c RHODES UNIVERSITY   (South Africa)

Author keywords

Betamethasone 17 valerate; Chromameter; Human skin blanching assay; Topical bioavailability; Topical corticosteroids; Vasoconstriction

Indexed keywords

BETAMETHASONE VALERATE;

ADULT; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; FEMALE; HUMAN; MALE; NORMAL HUMAN; REPRODUCIBILITY; TOPICAL DRUG ADMINISTRATION; VASOCONSTRICTION;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE 17-VALERATE; CALIBRATION; CHEMISTRY, PHARMACEUTICAL; GLUCOCORTICOIDS; HUMANS; OINTMENTS; SKIN; THERAPEUTIC EQUIVALENCY;

EID: 0033030401     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(98)00094-0     Document Type: Article

References (16)

1. Seidenari S., Di Nardo A., Montavani L., Giannetti A. Parallel intraindividual evaluation of the vasoconstrictory action and the anti-allergic activity of topical corticosteroids. Exp. Dermatol. 6:1997;75-80.
2. Cornell R.C., Stoughton R.B. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch. Dermatol. 121:1985;63-67.
3. Gibson J.R., Kirsch J.M., Darley C.R., Harvey S.G., Burke C.A., Hanson M.E. An assessment of the relationship between vasoconstrictor assay findings, clinical efficacy and skin thinning effects of a variety of undiluted and diluted corticosteroid preparations. Br. J. Dermatol. 111(27):1984;204-212.
4. Barry B.W., Woodford R. Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels. Br. J. Dermatol. 91:1974;323-338.
5. E.W. Smith, E. Meyer, J.M. Haigh, The human skin blanching assay for topical corticosteroid bioavailability assessment, in: V.P. Shah, H.I. Maibach (Eds.), Topical drug bioavailability, bioequivalence, and penetration, Plenum Press, New York, 1993, pp. 155-162.
6. W.P. Adams, G.J.P. Singh, Guidance: topical dermatologic corticosteroids: in vivo bioequivalence, Division of Bioequivalence, Office of Generic Drugs, Food and Drug Administration, 1995.
7. Haigh J.M., Meyer E., Smith E.W., Kanfer I. The human skin blanching assay for in vivo topical corticosteroid assessment. I. Reproducibility of the assay. Int. J. Pharm. 152:1997;179-183.
8. Haigh J.M., Meyer E., Smith E.W., Kanfer I. The human skin blanching assay for in vivo topical corticosteroid assessment II. Subject- and observer-dependent variation in blanching responses. Int. J. Pharm. 152:1997;185-192.
9. Robertson A.R. The CIE 1976 color-difference formulae. Color Res. Appl. 2:1977;7-11.
10. Fullerton A., Lahti A., Wilhelm K.-P., Perrenoud D., Serup J. Interlaboratory comparison and validity study of the Minolta Chromameter CR-200 and CR-300. Skin Res. Technol. 2:1996;126-135.
11. Meyer E., Smith E.W., Haigh J.M. Sensitivity of different areas of the flexor aspect of the human forearm to corticosteroid-induced skin blanching. Br. J. Dermatol. 127:1992;379-381.
12. E.W. Smith, E. Meyer, J.M. Haigh, Accuracy and reproducibility of the multiple-reading skin blanching assay, in: H.I. Maibach, C. Surber (Eds.), Topical Corticosteroids, S Karger AG, Basel, 1992, pp. 65-73.
13. Waring M.J., Monger L., Hollingsbee D.A., Martin G.P., Marriott C. Assessment of corticosteroid-induced skin blanching: evaluation of the Minolta Chromameter CR200. Int. J. Pharm. 94:1993;211-222.
14. Locke C.S. An exact confidence interval from untransformed data for the ratio of two formulation means. J. Pharmacokinet. Biopharm. 12:1984;649-655.
15. Wissenschaftliche Tabellen Geigy, Ciba-Geigy, Basel, 1980, p. 30.
16. Wissenschaftliche Tabellen Geigy, Ciba-Geigy., Basel, 1980, pp. 64-65, 217.